nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—Metoclopramide—Sunitinib—pancreatic cancer	0.8	1	CrCrCtD
Amisulpride—HTR7—enteric nervous system—pancreatic cancer	0.0127	0.561	CbGeAlD
Amisulpride—HTR2A—enteric nervous system—pancreatic cancer	0.0079	0.35	CbGeAlD
Amisulpride—HTR2B—digestive system—pancreatic cancer	0.000849	0.0376	CbGeAlD
Amisulpride—HTR7—digestive system—pancreatic cancer	0.000727	0.0322	CbGeAlD
Amisulpride—HTR2A—digestive system—pancreatic cancer	0.000453	0.0201	CbGeAlD
Amisulpride—Leukopenia—Sunitinib—pancreatic cancer	0.00036	0.00325	CcSEcCtD
Amisulpride—Pulmonary embolism—Epirubicin—pancreatic cancer	0.000354	0.00319	CcSEcCtD
Amisulpride—Ventricular tachycardia—Epirubicin—pancreatic cancer	0.000354	0.00319	CcSEcCtD
Amisulpride—Vaginal inflammation—Epirubicin—pancreatic cancer	0.000354	0.00319	CcSEcCtD
Amisulpride—Cardiac disorder—Irinotecan—pancreatic cancer	0.000353	0.00318	CcSEcCtD
Amisulpride—Convulsion—Sunitinib—pancreatic cancer	0.000349	0.00314	CcSEcCtD
Amisulpride—Dyskinesia—Doxorubicin—pancreatic cancer	0.000348	0.00314	CcSEcCtD
Amisulpride—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000348	0.00313	CcSEcCtD
Amisulpride—Hypertension—Sunitinib—pancreatic cancer	0.000347	0.00313	CcSEcCtD
Amisulpride—Insomnia—Tamoxifen—pancreatic cancer	0.000347	0.00312	CcSEcCtD
Amisulpride—Angiopathy—Irinotecan—pancreatic cancer	0.000346	0.00311	CcSEcCtD
Amisulpride—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000344	0.0031	CcSEcCtD
Amisulpride—Immune system disorder—Irinotecan—pancreatic cancer	0.000344	0.0031	CcSEcCtD
Amisulpride—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.000343	0.00309	CcSEcCtD
Amisulpride—Insomnia—Erlotinib—pancreatic cancer	0.000343	0.00309	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00034	0.00307	CcSEcCtD
Amisulpride—Dyspepsia—Tamoxifen—pancreatic cancer	0.000338	0.00304	CcSEcCtD
Amisulpride—Angiopathy—Gemcitabine—pancreatic cancer	0.000337	0.00303	CcSEcCtD
Amisulpride—Dry mouth—Sunitinib—pancreatic cancer	0.000335	0.00302	CcSEcCtD
Amisulpride—Immune system disorder—Gemcitabine—pancreatic cancer	0.000335	0.00302	CcSEcCtD
Amisulpride—Dyspepsia—Erlotinib—pancreatic cancer	0.000334	0.00301	CcSEcCtD
Amisulpride—Vaginal infection—Epirubicin—pancreatic cancer	0.000334	0.00301	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000331	0.00298	CcSEcCtD
Amisulpride—Fatigue—Tamoxifen—pancreatic cancer	0.000331	0.00298	CcSEcCtD
Amisulpride—Constipation—Tamoxifen—pancreatic cancer	0.000328	0.00295	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000328	0.00295	CcSEcCtD
Amisulpride—Ventricular tachycardia—Doxorubicin—pancreatic cancer	0.000327	0.00295	CcSEcCtD
Amisulpride—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.000327	0.00295	CcSEcCtD
Amisulpride—Pulmonary embolism—Doxorubicin—pancreatic cancer	0.000327	0.00295	CcSEcCtD
Amisulpride—Fatigue—Erlotinib—pancreatic cancer	0.000327	0.00295	CcSEcCtD
Amisulpride—Constipation—Erlotinib—pancreatic cancer	0.000324	0.00292	CcSEcCtD
Amisulpride—Nervous system disorder—Sunitinib—pancreatic cancer	0.000322	0.0029	CcSEcCtD
Amisulpride—Skin disorder—Sunitinib—pancreatic cancer	0.000319	0.00287	CcSEcCtD
Amisulpride—Muscle spasms—Irinotecan—pancreatic cancer	0.000319	0.00287	CcSEcCtD
Amisulpride—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.000318	0.00286	CcSEcCtD
Amisulpride—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000314	0.00282	CcSEcCtD
Amisulpride—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00031	0.00279	CcSEcCtD
Amisulpride—Vaginal infection—Doxorubicin—pancreatic cancer	0.000309	0.00278	CcSEcCtD
Amisulpride—Neutropenia—Docetaxel—pancreatic cancer	0.000308	0.00277	CcSEcCtD
Amisulpride—Urticaria—Tamoxifen—pancreatic cancer	0.000305	0.00274	CcSEcCtD
Amisulpride—Abdominal pain—Tamoxifen—pancreatic cancer	0.000303	0.00273	CcSEcCtD
Amisulpride—Abdominal pain—Erlotinib—pancreatic cancer	0.0003	0.0027	CcSEcCtD
Amisulpride—Weight increased—Docetaxel—pancreatic cancer	0.000299	0.0027	CcSEcCtD
Amisulpride—Weight decreased—Docetaxel—pancreatic cancer	0.000298	0.00268	CcSEcCtD
Amisulpride—Insomnia—Sunitinib—pancreatic cancer	0.000297	0.00268	CcSEcCtD
Amisulpride—Leukopenia—Irinotecan—pancreatic cancer	0.000297	0.00267	CcSEcCtD
Amisulpride—Dyspepsia—Sunitinib—pancreatic cancer	0.000289	0.0026	CcSEcCtD
Amisulpride—Leukopenia—Gemcitabine—pancreatic cancer	0.000289	0.0026	CcSEcCtD
Amisulpride—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000287	0.00259	CcSEcCtD
Amisulpride—Hypertension—Irinotecan—pancreatic cancer	0.000286	0.00258	CcSEcCtD
Amisulpride—Leukopenia—Fluorouracil—pancreatic cancer	0.000284	0.00256	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000284	0.00255	CcSEcCtD
Amisulpride—Fatigue—Sunitinib—pancreatic cancer	0.000283	0.00255	CcSEcCtD
Amisulpride—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000283	0.00255	CcSEcCtD
Amisulpride—Constipation—Sunitinib—pancreatic cancer	0.000281	0.00253	CcSEcCtD
Amisulpride—Hypertension—Gemcitabine—pancreatic cancer	0.000279	0.00251	CcSEcCtD
Amisulpride—Asthenia—Tamoxifen—pancreatic cancer	0.000275	0.00248	CcSEcCtD
Amisulpride—Convulsion—Fluorouracil—pancreatic cancer	0.000275	0.00248	CcSEcCtD
Amisulpride—Agranulocytosis—Docetaxel—pancreatic cancer	0.000274	0.00247	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000273	0.00246	CcSEcCtD
Amisulpride—Asthenia—Erlotinib—pancreatic cancer	0.000272	0.00245	CcSEcCtD
Amisulpride—Pruritus—Tamoxifen—pancreatic cancer	0.000271	0.00244	CcSEcCtD
Amisulpride—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000269	0.00242	CcSEcCtD
Amisulpride—Pruritus—Erlotinib—pancreatic cancer	0.000268	0.00242	CcSEcCtD
Amisulpride—Nervous system disorder—Irinotecan—pancreatic cancer	0.000265	0.00239	CcSEcCtD
Amisulpride—Diarrhoea—Tamoxifen—pancreatic cancer	0.000262	0.00236	CcSEcCtD
Amisulpride—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000262	0.00236	CcSEcCtD
Amisulpride—Abdominal pain—Sunitinib—pancreatic cancer	0.00026	0.00234	CcSEcCtD
Amisulpride—Diarrhoea—Erlotinib—pancreatic cancer	0.00026	0.00234	CcSEcCtD
Amisulpride—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000258	0.00233	CcSEcCtD
Amisulpride—Skin disorder—Gemcitabine—pancreatic cancer	0.000256	0.00231	CcSEcCtD
Amisulpride—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000255	0.0023	CcSEcCtD
Amisulpride—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000254	0.00229	CcSEcCtD
Amisulpride—Dizziness—Tamoxifen—pancreatic cancer	0.000254	0.00228	CcSEcCtD
Amisulpride—Hypotension—Irinotecan—pancreatic cancer	0.000253	0.00228	CcSEcCtD
Amisulpride—Dizziness—Erlotinib—pancreatic cancer	0.000251	0.00226	CcSEcCtD
Amisulpride—Hypotension—Gemcitabine—pancreatic cancer	0.000246	0.00222	CcSEcCtD
Amisulpride—Insomnia—Irinotecan—pancreatic cancer	0.000245	0.0022	CcSEcCtD
Amisulpride—Cardiac disorder—Docetaxel—pancreatic cancer	0.000244	0.0022	CcSEcCtD
Amisulpride—Cardiac arrest—Epirubicin—pancreatic cancer	0.000244	0.0022	CcSEcCtD
Amisulpride—Vomiting—Tamoxifen—pancreatic cancer	0.000244	0.0022	CcSEcCtD
Amisulpride—Hypotension—Fluorouracil—pancreatic cancer	0.000242	0.00218	CcSEcCtD
Amisulpride—Hypersensitivity—Sunitinib—pancreatic cancer	0.000242	0.00218	CcSEcCtD
Amisulpride—Vomiting—Erlotinib—pancreatic cancer	0.000241	0.00217	CcSEcCtD
Amisulpride—Somnolence—Irinotecan—pancreatic cancer	0.000241	0.00217	CcSEcCtD
Amisulpride—Headache—Tamoxifen—pancreatic cancer	0.00024	0.00216	CcSEcCtD
Amisulpride—Angiopathy—Docetaxel—pancreatic cancer	0.000239	0.00215	CcSEcCtD
Amisulpride—Insomnia—Gemcitabine—pancreatic cancer	0.000238	0.00215	CcSEcCtD
Amisulpride—Dyspepsia—Irinotecan—pancreatic cancer	0.000238	0.00215	CcSEcCtD
Amisulpride—Immune system disorder—Docetaxel—pancreatic cancer	0.000238	0.00214	CcSEcCtD
Amisulpride—Headache—Erlotinib—pancreatic cancer	0.000238	0.00214	CcSEcCtD
Amisulpride—Asthenia—Sunitinib—pancreatic cancer	0.000236	0.00212	CcSEcCtD
Amisulpride—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000234	0.00211	CcSEcCtD
Amisulpride—Insomnia—Fluorouracil—pancreatic cancer	0.000234	0.00211	CcSEcCtD
Amisulpride—Somnolence—Gemcitabine—pancreatic cancer	0.000234	0.00211	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000234	0.0021	CcSEcCtD
Amisulpride—Fatigue—Irinotecan—pancreatic cancer	0.000233	0.0021	CcSEcCtD
Amisulpride—Pruritus—Sunitinib—pancreatic cancer	0.000232	0.00209	CcSEcCtD
Amisulpride—Constipation—Irinotecan—pancreatic cancer	0.000231	0.00208	CcSEcCtD
Amisulpride—Mental disorder—Docetaxel—pancreatic cancer	0.000231	0.00208	CcSEcCtD
Amisulpride—Somnolence—Fluorouracil—pancreatic cancer	0.00023	0.00208	CcSEcCtD
Amisulpride—Malnutrition—Docetaxel—pancreatic cancer	0.000229	0.00206	CcSEcCtD
Amisulpride—Dyspepsia—Fluorouracil—pancreatic cancer	0.000228	0.00205	CcSEcCtD
Amisulpride—Nausea—Tamoxifen—pancreatic cancer	0.000228	0.00205	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000228	0.00205	CcSEcCtD
Amisulpride—Fatigue—Gemcitabine—pancreatic cancer	0.000227	0.00205	CcSEcCtD
Amisulpride—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000226	0.00203	CcSEcCtD
Amisulpride—Constipation—Gemcitabine—pancreatic cancer	0.000225	0.00203	CcSEcCtD
Amisulpride—Nausea—Erlotinib—pancreatic cancer	0.000225	0.00203	CcSEcCtD
Amisulpride—Diarrhoea—Sunitinib—pancreatic cancer	0.000225	0.00202	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000224	0.00202	CcSEcCtD
Amisulpride—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000221	0.00199	CcSEcCtD
Amisulpride—Muscle spasms—Docetaxel—pancreatic cancer	0.00022	0.00198	CcSEcCtD
Amisulpride—Dizziness—Sunitinib—pancreatic cancer	0.000217	0.00196	CcSEcCtD
Amisulpride—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000217	0.00195	CcSEcCtD
Amisulpride—Abdominal pain—Irinotecan—pancreatic cancer	0.000214	0.00193	CcSEcCtD
Amisulpride—Vomiting—Sunitinib—pancreatic cancer	0.000209	0.00188	CcSEcCtD
Amisulpride—Neutropenia—Epirubicin—pancreatic cancer	0.000207	0.00187	CcSEcCtD
Amisulpride—Urticaria—Fluorouracil—pancreatic cancer	0.000206	0.00185	CcSEcCtD
Amisulpride—Headache—Sunitinib—pancreatic cancer	0.000206	0.00185	CcSEcCtD
Amisulpride—Leukopenia—Docetaxel—pancreatic cancer	0.000205	0.00185	CcSEcCtD
Amisulpride—Weight increased—Epirubicin—pancreatic cancer	0.000202	0.00182	CcSEcCtD
Amisulpride—Weight decreased—Epirubicin—pancreatic cancer	0.000201	0.00181	CcSEcCtD
Amisulpride—Hyperglycaemia—Epirubicin—pancreatic cancer	0.0002	0.0018	CcSEcCtD
Amisulpride—Hypersensitivity—Irinotecan—pancreatic cancer	0.000199	0.0018	CcSEcCtD
Amisulpride—Convulsion—Docetaxel—pancreatic cancer	0.000199	0.00179	CcSEcCtD
Amisulpride—Hypertension—Docetaxel—pancreatic cancer	0.000198	0.00178	CcSEcCtD
Amisulpride—Nausea—Sunitinib—pancreatic cancer	0.000195	0.00176	CcSEcCtD
Amisulpride—Asthenia—Irinotecan—pancreatic cancer	0.000194	0.00175	CcSEcCtD
Amisulpride—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000194	0.00175	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000194	0.00175	CcSEcCtD
Amisulpride—Neutropenia—Doxorubicin—pancreatic cancer	0.000192	0.00173	CcSEcCtD
Amisulpride—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000191	0.00172	CcSEcCtD
Amisulpride—Dry mouth—Docetaxel—pancreatic cancer	0.000191	0.00172	CcSEcCtD
Amisulpride—Asthenia—Gemcitabine—pancreatic cancer	0.000189	0.0017	CcSEcCtD
Amisulpride—Weight increased—Doxorubicin—pancreatic cancer	0.000187	0.00168	CcSEcCtD
Amisulpride—Pruritus—Gemcitabine—pancreatic cancer	0.000186	0.00168	CcSEcCtD
Amisulpride—Weight decreased—Doxorubicin—pancreatic cancer	0.000186	0.00167	CcSEcCtD
Amisulpride—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000185	0.00167	CcSEcCtD
Amisulpride—Diarrhoea—Irinotecan—pancreatic cancer	0.000185	0.00167	CcSEcCtD
Amisulpride—Agranulocytosis—Epirubicin—pancreatic cancer	0.000185	0.00166	CcSEcCtD
Amisulpride—Nervous system disorder—Docetaxel—pancreatic cancer	0.000183	0.00165	CcSEcCtD
Amisulpride—Pruritus—Fluorouracil—pancreatic cancer	0.000183	0.00165	CcSEcCtD
Amisulpride—Skin disorder—Docetaxel—pancreatic cancer	0.000182	0.00164	CcSEcCtD
Amisulpride—Bradycardia—Epirubicin—pancreatic cancer	0.000181	0.00163	CcSEcCtD
Amisulpride—Diarrhoea—Gemcitabine—pancreatic cancer	0.00018	0.00162	CcSEcCtD
Amisulpride—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000179	0.00162	CcSEcCtD
Amisulpride—Dizziness—Irinotecan—pancreatic cancer	0.000179	0.00161	CcSEcCtD
Amisulpride—Diarrhoea—Fluorouracil—pancreatic cancer	0.000177	0.0016	CcSEcCtD
Amisulpride—Hypotension—Docetaxel—pancreatic cancer	0.000175	0.00157	CcSEcCtD
Amisulpride—Vomiting—Irinotecan—pancreatic cancer	0.000172	0.00155	CcSEcCtD
Amisulpride—Dizziness—Fluorouracil—pancreatic cancer	0.000171	0.00154	CcSEcCtD
Amisulpride—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000171	0.00154	CcSEcCtD
Amisulpride—Headache—Irinotecan—pancreatic cancer	0.00017	0.00153	CcSEcCtD
Amisulpride—Insomnia—Docetaxel—pancreatic cancer	0.000169	0.00152	CcSEcCtD
Amisulpride—Vomiting—Gemcitabine—pancreatic cancer	0.000168	0.00151	CcSEcCtD
Amisulpride—Bradycardia—Doxorubicin—pancreatic cancer	0.000167	0.00151	CcSEcCtD
Amisulpride—Somnolence—Docetaxel—pancreatic cancer	0.000166	0.0015	CcSEcCtD
Amisulpride—Headache—Gemcitabine—pancreatic cancer	0.000165	0.00149	CcSEcCtD
Amisulpride—Cardiac disorder—Epirubicin—pancreatic cancer	0.000165	0.00148	CcSEcCtD
Amisulpride—Vomiting—Fluorouracil—pancreatic cancer	0.000165	0.00148	CcSEcCtD
Amisulpride—Dyspepsia—Docetaxel—pancreatic cancer	0.000165	0.00148	CcSEcCtD
Amisulpride—Headache—Fluorouracil—pancreatic cancer	0.000162	0.00146	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000161	0.00145	CcSEcCtD
Amisulpride—Fatigue—Docetaxel—pancreatic cancer	0.000161	0.00145	CcSEcCtD
Amisulpride—Angiopathy—Epirubicin—pancreatic cancer	0.000161	0.00145	CcSEcCtD
Amisulpride—Nausea—Irinotecan—pancreatic cancer	0.000161	0.00145	CcSEcCtD
Amisulpride—Immune system disorder—Epirubicin—pancreatic cancer	0.00016	0.00144	CcSEcCtD
Amisulpride—Constipation—Docetaxel—pancreatic cancer	0.00016	0.00144	CcSEcCtD
Amisulpride—Nausea—Gemcitabine—pancreatic cancer	0.000157	0.00141	CcSEcCtD
Amisulpride—Mental disorder—Epirubicin—pancreatic cancer	0.000156	0.0014	CcSEcCtD
Amisulpride—Malnutrition—Epirubicin—pancreatic cancer	0.000155	0.00139	CcSEcCtD
Amisulpride—Nausea—Fluorouracil—pancreatic cancer	0.000154	0.00139	CcSEcCtD
Amisulpride—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000153	0.00138	CcSEcCtD
Amisulpride—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000152	0.00137	CcSEcCtD
Amisulpride—Tension—Epirubicin—pancreatic cancer	0.000152	0.00137	CcSEcCtD
Amisulpride—Nervousness—Epirubicin—pancreatic cancer	0.00015	0.00135	CcSEcCtD
Amisulpride—Angiopathy—Doxorubicin—pancreatic cancer	0.000149	0.00134	CcSEcCtD
Amisulpride—Muscle spasms—Epirubicin—pancreatic cancer	0.000149	0.00134	CcSEcCtD
Amisulpride—Immune system disorder—Doxorubicin—pancreatic cancer	0.000148	0.00134	CcSEcCtD
Amisulpride—Abdominal pain—Docetaxel—pancreatic cancer	0.000148	0.00133	CcSEcCtD
Amisulpride—Mental disorder—Doxorubicin—pancreatic cancer	0.000144	0.0013	CcSEcCtD
Amisulpride—Malnutrition—Doxorubicin—pancreatic cancer	0.000143	0.00129	CcSEcCtD
Amisulpride—Agitation—Epirubicin—pancreatic cancer	0.000142	0.00128	CcSEcCtD
Amisulpride—Tension—Doxorubicin—pancreatic cancer	0.00014	0.00126	CcSEcCtD
Amisulpride—Nervousness—Doxorubicin—pancreatic cancer	0.000139	0.00125	CcSEcCtD
Amisulpride—Leukopenia—Epirubicin—pancreatic cancer	0.000138	0.00125	CcSEcCtD
Amisulpride—Hypersensitivity—Docetaxel—pancreatic cancer	0.000138	0.00124	CcSEcCtD
Amisulpride—Muscle spasms—Doxorubicin—pancreatic cancer	0.000138	0.00124	CcSEcCtD
Amisulpride—Asthenia—Docetaxel—pancreatic cancer	0.000134	0.00121	CcSEcCtD
Amisulpride—Convulsion—Epirubicin—pancreatic cancer	0.000134	0.00121	CcSEcCtD
Amisulpride—Hypertension—Epirubicin—pancreatic cancer	0.000133	0.0012	CcSEcCtD
Amisulpride—Pruritus—Docetaxel—pancreatic cancer	0.000132	0.00119	CcSEcCtD
Amisulpride—Agitation—Doxorubicin—pancreatic cancer	0.000131	0.00118	CcSEcCtD
Amisulpride—Anxiety—Epirubicin—pancreatic cancer	0.000131	0.00118	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000131	0.00118	CcSEcCtD
Amisulpride—Dry mouth—Epirubicin—pancreatic cancer	0.000129	0.00116	CcSEcCtD
Amisulpride—Leukopenia—Doxorubicin—pancreatic cancer	0.000128	0.00115	CcSEcCtD
Amisulpride—Diarrhoea—Docetaxel—pancreatic cancer	0.000128	0.00115	CcSEcCtD
Amisulpride—Convulsion—Doxorubicin—pancreatic cancer	0.000124	0.00112	CcSEcCtD
Amisulpride—Nervous system disorder—Epirubicin—pancreatic cancer	0.000124	0.00111	CcSEcCtD
Amisulpride—Dizziness—Docetaxel—pancreatic cancer	0.000124	0.00111	CcSEcCtD
Amisulpride—Hypertension—Doxorubicin—pancreatic cancer	0.000123	0.00111	CcSEcCtD
Amisulpride—Skin disorder—Epirubicin—pancreatic cancer	0.000123	0.0011	CcSEcCtD
Amisulpride—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000122	0.0011	CcSEcCtD
Amisulpride—Anxiety—Doxorubicin—pancreatic cancer	0.000121	0.00109	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000121	0.00109	CcSEcCtD
Amisulpride—Dry mouth—Doxorubicin—pancreatic cancer	0.000119	0.00107	CcSEcCtD
Amisulpride—Vomiting—Docetaxel—pancreatic cancer	0.000119	0.00107	CcSEcCtD
Amisulpride—Hypotension—Epirubicin—pancreatic cancer	0.000118	0.00106	CcSEcCtD
Amisulpride—Headache—Docetaxel—pancreatic cancer	0.000117	0.00106	CcSEcCtD
Amisulpride—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000114	0.00103	CcSEcCtD
Amisulpride—Insomnia—Epirubicin—pancreatic cancer	0.000114	0.00103	CcSEcCtD
Amisulpride—Skin disorder—Doxorubicin—pancreatic cancer	0.000113	0.00102	CcSEcCtD
Amisulpride—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000113	0.00102	CcSEcCtD
Amisulpride—Somnolence—Epirubicin—pancreatic cancer	0.000112	0.00101	CcSEcCtD
Amisulpride—Nausea—Docetaxel—pancreatic cancer	0.000111	0.001	CcSEcCtD
Amisulpride—Dyspepsia—Epirubicin—pancreatic cancer	0.000111	0.001	CcSEcCtD
Amisulpride—Hypotension—Doxorubicin—pancreatic cancer	0.000109	0.000983	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000109	0.000981	CcSEcCtD
Amisulpride—Fatigue—Epirubicin—pancreatic cancer	0.000109	0.00098	CcSEcCtD
Amisulpride—Constipation—Epirubicin—pancreatic cancer	0.000108	0.000972	CcSEcCtD
Amisulpride—Insomnia—Doxorubicin—pancreatic cancer	0.000106	0.000951	CcSEcCtD
Amisulpride—Somnolence—Doxorubicin—pancreatic cancer	0.000104	0.000935	CcSEcCtD
Amisulpride—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000103	0.000929	CcSEcCtD
Amisulpride—Dyspepsia—Doxorubicin—pancreatic cancer	0.000103	0.000926	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000101	0.000908	CcSEcCtD
Amisulpride—Fatigue—Doxorubicin—pancreatic cancer	0.000101	0.000907	CcSEcCtD
Amisulpride—Urticaria—Epirubicin—pancreatic cancer	0.0001	0.000903	CcSEcCtD
Amisulpride—Constipation—Doxorubicin—pancreatic cancer	9.98e-05	0.000899	CcSEcCtD
Amisulpride—Abdominal pain—Epirubicin—pancreatic cancer	9.97e-05	0.000898	CcSEcCtD
Amisulpride—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.55e-05	0.00086	CcSEcCtD
Amisulpride—Hypersensitivity—Epirubicin—pancreatic cancer	9.29e-05	0.000837	CcSEcCtD
Amisulpride—Urticaria—Doxorubicin—pancreatic cancer	9.27e-05	0.000835	CcSEcCtD
Amisulpride—Abdominal pain—Doxorubicin—pancreatic cancer	9.23e-05	0.000831	CcSEcCtD
Amisulpride—Asthenia—Epirubicin—pancreatic cancer	9.05e-05	0.000815	CcSEcCtD
Amisulpride—Pruritus—Epirubicin—pancreatic cancer	8.93e-05	0.000804	CcSEcCtD
Amisulpride—Diarrhoea—Epirubicin—pancreatic cancer	8.63e-05	0.000778	CcSEcCtD
Amisulpride—Hypersensitivity—Doxorubicin—pancreatic cancer	8.6e-05	0.000775	CcSEcCtD
Amisulpride—Asthenia—Doxorubicin—pancreatic cancer	8.38e-05	0.000754	CcSEcCtD
Amisulpride—Dizziness—Epirubicin—pancreatic cancer	8.34e-05	0.000751	CcSEcCtD
Amisulpride—Pruritus—Doxorubicin—pancreatic cancer	8.26e-05	0.000744	CcSEcCtD
Amisulpride—Vomiting—Epirubicin—pancreatic cancer	8.02e-05	0.000723	CcSEcCtD
Amisulpride—Diarrhoea—Doxorubicin—pancreatic cancer	7.99e-05	0.000719	CcSEcCtD
Amisulpride—Headache—Epirubicin—pancreatic cancer	7.9e-05	0.000712	CcSEcCtD
Amisulpride—Dizziness—Doxorubicin—pancreatic cancer	7.72e-05	0.000695	CcSEcCtD
Amisulpride—Nausea—Epirubicin—pancreatic cancer	7.49e-05	0.000675	CcSEcCtD
Amisulpride—Vomiting—Doxorubicin—pancreatic cancer	7.42e-05	0.000669	CcSEcCtD
Amisulpride—Headache—Doxorubicin—pancreatic cancer	7.31e-05	0.000659	CcSEcCtD
Amisulpride—Nausea—Doxorubicin—pancreatic cancer	6.93e-05	0.000625	CcSEcCtD
Amisulpride—DRD2—Signaling Pathways—NOTCH4—pancreatic cancer	2.22e-05	0.000332	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IAPP—pancreatic cancer	2.2e-05	0.00033	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SHH—pancreatic cancer	2.2e-05	0.000329	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.19e-05	0.000328	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SMAD4—pancreatic cancer	2.18e-05	0.000327	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOTCH4—pancreatic cancer	2.18e-05	0.000327	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IAPP—pancreatic cancer	2.17e-05	0.000325	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CXCL8—pancreatic cancer	2.16e-05	0.000323	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGTR1—pancreatic cancer	2.15e-05	0.000322	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CD—pancreatic cancer	2.14e-05	0.00032	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HES1—pancreatic cancer	2.13e-05	0.000319	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STK11—pancreatic cancer	2.12e-05	0.000317	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTHLH—pancreatic cancer	2.12e-05	0.000317	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTCH1—pancreatic cancer	2.12e-05	0.000317	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTCH1—pancreatic cancer	2.08e-05	0.000312	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTHLH—pancreatic cancer	2.08e-05	0.000312	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.05e-05	0.000307	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CB—pancreatic cancer	2.04e-05	0.000306	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SMAD4—pancreatic cancer	1.99e-05	0.000299	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CD—pancreatic cancer	1.99e-05	0.000298	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CXCL8—pancreatic cancer	1.97e-05	0.000295	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CXCL8—pancreatic cancer	1.96e-05	0.000294	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HES1—pancreatic cancer	1.95e-05	0.000292	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SST—pancreatic cancer	1.94e-05	0.00029	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.91e-05	0.000286	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.91e-05	0.000286	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SST—pancreatic cancer	1.9e-05	0.000285	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JAG1—pancreatic cancer	1.89e-05	0.000283	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOTCH3—pancreatic cancer	1.89e-05	0.000282	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.88e-05	0.000281	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TERT—pancreatic cancer	1.87e-05	0.00028	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CB—pancreatic cancer	1.87e-05	0.000279	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JAG1—pancreatic cancer	1.86e-05	0.000279	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SMAD4—pancreatic cancer	1.86e-05	0.000278	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOTCH3—pancreatic cancer	1.86e-05	0.000278	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CXCL8—pancreatic cancer	1.84e-05	0.000275	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HES1—pancreatic cancer	1.81e-05	0.000271	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CXCL8—pancreatic cancer	1.79e-05	0.000268	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HIF1A—pancreatic cancer	1.79e-05	0.000267	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CNR1—pancreatic cancer	1.79e-05	0.000267	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TSC2—pancreatic cancer	1.78e-05	0.000267	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CNR1—pancreatic cancer	1.76e-05	0.000263	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APOE—pancreatic cancer	1.74e-05	0.000261	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CB—pancreatic cancer	1.74e-05	0.00026	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.73e-05	0.000259	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GCG—pancreatic cancer	1.72e-05	0.000258	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KDR—pancreatic cancer	1.71e-05	0.000256	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TERT—pancreatic cancer	1.71e-05	0.000256	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CG—pancreatic cancer	1.71e-05	0.000255	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GCG—pancreatic cancer	1.7e-05	0.000254	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.68e-05	0.000251	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CXCL8—pancreatic cancer	1.67e-05	0.00025	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.65e-05	0.000247	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGTR1—pancreatic cancer	1.65e-05	0.000246	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HIF1A—pancreatic cancer	1.63e-05	0.000244	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TSC2—pancreatic cancer	1.63e-05	0.000244	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NFKBIA—pancreatic cancer	1.62e-05	0.000243	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STK11—pancreatic cancer	1.62e-05	0.000243	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGTR1—pancreatic cancer	1.62e-05	0.000242	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NOTCH1—pancreatic cancer	1.61e-05	0.000241	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STK11—pancreatic cancer	1.6e-05	0.000239	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOE—pancreatic cancer	1.59e-05	0.000239	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TERT—pancreatic cancer	1.59e-05	0.000238	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CG—pancreatic cancer	1.57e-05	0.000236	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—NRAS—pancreatic cancer	1.57e-05	0.000236	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KDR—pancreatic cancer	1.56e-05	0.000234	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGF—pancreatic cancer	1.56e-05	0.000233	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.52e-05	0.000228	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HIF1A—pancreatic cancer	1.52e-05	0.000227	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TSC2—pancreatic cancer	1.51e-05	0.000227	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.5e-05	0.000224	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NFKBIA—pancreatic cancer	1.48e-05	0.000222	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOE—pancreatic cancer	1.48e-05	0.000222	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NOTCH1—pancreatic cancer	1.47e-05	0.00022	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.46e-05	0.000219	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KDR—pancreatic cancer	1.45e-05	0.000217	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.44e-05	0.000215	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CG—pancreatic cancer	1.44e-05	0.000215	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—NRAS—pancreatic cancer	1.44e-05	0.000215	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—EGFR—pancreatic cancer	1.43e-05	0.000215	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGF—pancreatic cancer	1.42e-05	0.000213	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	1.42e-05	0.000213	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.41e-05	0.00021	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SMAD4—pancreatic cancer	1.4e-05	0.000209	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HES1—pancreatic cancer	1.39e-05	0.000208	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CD—pancreatic cancer	1.38e-05	0.000207	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.38e-05	0.000207	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NFKBIA—pancreatic cancer	1.38e-05	0.000207	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.37e-05	0.000205	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NOTCH1—pancreatic cancer	1.37e-05	0.000205	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HES1—pancreatic cancer	1.36e-05	0.000204	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—KRAS—pancreatic cancer	1.35e-05	0.000203	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CG—pancreatic cancer	1.34e-05	0.0002	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—NRAS—pancreatic cancer	1.34e-05	0.0002	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.33e-05	0.000199	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGF—pancreatic cancer	1.32e-05	0.000198	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—EGFR—pancreatic cancer	1.31e-05	0.000196	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.31e-05	0.000196	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	1.28e-05	0.000191	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CD—pancreatic cancer	1.26e-05	0.000189	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.26e-05	0.000188	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.25e-05	0.000187	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CA—pancreatic cancer	1.24e-05	0.000186	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—KRAS—pancreatic cancer	1.24e-05	0.000185	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—EGFR—pancreatic cancer	1.22e-05	0.000182	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TERT—pancreatic cancer	1.22e-05	0.000182	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CB—pancreatic cancer	1.21e-05	0.000181	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TERT—pancreatic cancer	1.2e-05	0.000179	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CD—pancreatic cancer	1.18e-05	0.000176	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.17e-05	0.000174	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	1.16e-05	0.000174	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TSC2—pancreatic cancer	1.16e-05	0.000174	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL8—pancreatic cancer	1.16e-05	0.000173	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—KRAS—pancreatic cancer	1.15e-05	0.000172	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—HRAS—pancreatic cancer	1.15e-05	0.000172	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HIF1A—pancreatic cancer	1.14e-05	0.000171	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TSC2—pancreatic cancer	1.14e-05	0.000171	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.14e-05	0.00017	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOE—pancreatic cancer	1.13e-05	0.00017	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—pancreatic cancer	1.12e-05	0.000168	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOE—pancreatic cancer	1.12e-05	0.000167	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KDR—pancreatic cancer	1.11e-05	0.000166	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—pancreatic cancer	1.11e-05	0.000166	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.1e-05	0.000165	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KDR—pancreatic cancer	1.09e-05	0.000164	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCND1—pancreatic cancer	1.08e-05	0.000162	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CTNNB1—pancreatic cancer	1.07e-05	0.00016	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL8—pancreatic cancer	1.06e-05	0.000159	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.06e-05	0.000158	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	1.06e-05	0.000158	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—HRAS—pancreatic cancer	1.05e-05	0.000157	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—pancreatic cancer	1.05e-05	0.000157	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	1.05e-05	0.000157	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTEN—pancreatic cancer	1.04e-05	0.000156	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.04e-05	0.000156	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.03e-05	0.000154	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CB—pancreatic cancer	1.03e-05	0.000153	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	1.02e-05	0.000153	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	1.02e-05	0.000153	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.02e-05	0.000153	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—pancreatic cancer	1.02e-05	0.000152	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—pancreatic cancer	1.01e-05	0.000152	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGF—pancreatic cancer	1.01e-05	0.000152	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.01e-05	0.000151	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—NRAS—pancreatic cancer	1.01e-05	0.000151	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGF—pancreatic cancer	9.96e-06	0.000149	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCND1—pancreatic cancer	9.86e-06	0.000148	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL8—pancreatic cancer	9.85e-06	0.000147	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—HRAS—pancreatic cancer	9.79e-06	0.000147	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CTNNB1—pancreatic cancer	9.77e-06	0.000146	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SRC—pancreatic cancer	9.66e-06	0.000145	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—pancreatic cancer	9.58e-06	0.000143	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTEN—pancreatic cancer	9.52e-06	0.000143	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—pancreatic cancer	9.52e-06	0.000142	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—pancreatic cancer	9.43e-06	0.000141	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—pancreatic cancer	9.41e-06	0.000141	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	9.33e-06	0.00014	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—pancreatic cancer	9.32e-06	0.00014	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NRAS—pancreatic cancer	9.3e-06	0.000139	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—pancreatic cancer	9.29e-06	0.000139	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCND1—pancreatic cancer	9.18e-06	0.000137	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	9.18e-06	0.000137	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CTNNB1—pancreatic cancer	9.09e-06	0.000136	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	9e-06	0.000135	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.91e-06	0.000133	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—pancreatic cancer	8.91e-06	0.000133	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTEN—pancreatic cancer	8.86e-06	0.000133	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	8.86e-06	0.000133	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SRC—pancreatic cancer	8.83e-06	0.000132	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	8.81e-06	0.000132	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.77e-06	0.000131	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	8.67e-06	0.00013	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—pancreatic cancer	8.66e-06	0.00013	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—pancreatic cancer	8.64e-06	0.000129	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—pancreatic cancer	8.64e-06	0.000129	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—pancreatic cancer	8.6e-06	0.000129	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—pancreatic cancer	8.52e-06	0.000127	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NRAS—pancreatic cancer	8.49e-06	0.000127	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGFR—pancreatic cancer	8.47e-06	0.000127	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SRC—pancreatic cancer	8.22e-06	0.000123	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	8.1e-06	0.000121	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—pancreatic cancer	8e-06	0.00012	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KRAS—pancreatic cancer	8e-06	0.00012	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	7.97e-06	0.000119	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—pancreatic cancer	7.92e-06	0.000119	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—pancreatic cancer	7.91e-06	0.000118	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NRAS—pancreatic cancer	7.9e-06	0.000118	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	7.89e-06	0.000118	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	7.85e-06	0.000117	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	7.74e-06	0.000116	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	7.72e-06	0.000116	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	7.54e-06	0.000113	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	7.49e-06	0.000112	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	7.42e-06	0.000111	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	7.37e-06	0.00011	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—pancreatic cancer	7.36e-06	0.00011	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CA—pancreatic cancer	7.35e-06	0.00011	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	7.34e-06	0.00011	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	7.31e-06	0.000109	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	7.28e-06	0.000109	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—pancreatic cancer	7.22e-06	0.000108	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGFR—pancreatic cancer	7.2e-06	0.000108	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.17e-06	0.000107	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TP53—pancreatic cancer	7.11e-06	0.000106	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	7.1e-06	0.000106	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCND1—pancreatic cancer	7.02e-06	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	6.96e-06	0.000104	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	6.91e-06	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.84e-06	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—pancreatic cancer	6.82e-06	0.000102	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KRAS—pancreatic cancer	6.8e-06	0.000102	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HRAS—pancreatic cancer	6.8e-06	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTEN—pancreatic cancer	6.78e-06	0.000101	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	6.72e-06	0.000101	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	6.71e-06	0.0001	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	6.67e-06	9.99e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	6.61e-06	9.9e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	6.51e-06	9.74e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TP53—pancreatic cancer	6.5e-06	9.73e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SRC—pancreatic cancer	6.29e-06	9.41e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	6.25e-06	9.36e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	6.21e-06	9.3e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SRC—pancreatic cancer	6.19e-06	9.26e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	6.12e-06	9.17e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—pancreatic cancer	6.06e-06	9.08e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NRAS—pancreatic cancer	6.05e-06	9.05e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TP53—pancreatic cancer	6.05e-06	9.05e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	6.02e-06	9.02e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—pancreatic cancer	6e-06	8.99e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	5.97e-06	8.93e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	5.95e-06	8.91e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HRAS—pancreatic cancer	5.78e-06	8.66e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—pancreatic cancer	5.63e-06	8.43e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	5.62e-06	8.41e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—pancreatic cancer	5.54e-06	8.3e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	5.53e-06	8.28e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGFR—pancreatic cancer	5.51e-06	8.25e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	5.49e-06	8.21e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	5.42e-06	8.12e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KRAS—pancreatic cancer	5.21e-06	7.79e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	5.12e-06	7.67e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—pancreatic cancer	5.11e-06	7.64e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	4.78e-06	7.16e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.71e-06	7.04e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TP53—pancreatic cancer	4.63e-06	6.93e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TP53—pancreatic cancer	4.55e-06	6.82e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HRAS—pancreatic cancer	4.42e-06	6.62e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	4.35e-06	6.52e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—pancreatic cancer	3.91e-06	5.85e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	3.84e-06	5.75e-05	CbGpPWpGaD
